Drug Type Chemical drugs |
Synonyms TRX-221 |
Target |
Mechanism EGFR C797S inhibitors(Epidermal Growth Factor Receptor C797S inhibitors), EGFR T790M inhibitors(EGFR T790M inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Therapex Co., Ltd.Startup |
Active Organization Therapex Co., Ltd.Startup |
Inactive Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
EGFR-mutated non-small Cell Lung Cancer | Phase 2 | - | Therapex Co., Ltd.Startup | 30 Apr 2024 |
Non-Small Cell Lung Cancer | Preclinical | KR | Therapex Co., Ltd.Startup | 18 Apr 2023 |